Global Coalition on Aging Welcomes Attention to Heart Failure at 2019 European Society of Cardiology Congress; Calls for Greater Focus on the Connection Between Aging and Heart Failure

New York, NEW YORK (August 30, 2019) – Beginning Saturday, August 31st, the European Society of Cardiology (ESC) together with the World Congress of Cardiology (WCC) will highlight the impact of heart failure (HF) on older adults in select sessions during its 2019 Congress. The Congress’ attention on HF will include the launch of a Roadmap for Heart Failure created by the World Heart Federation, which provides a framework for policymakers, innovators, scientists, providers, patients, payers, and others to guide national initiatives to improve health outcomes and cost savings related to HF.

“Heart failure is a widespread and deadly disease, and for older adults, its symptoms are too often downplayed or dismissed altogether as normal effects of aging,” said Michael Hodin, PhD, CEO of the Global Coalition on Aging (GCOA). “While heart failure does increase in prevalence with age, it must not be conflated with the normal process of aging or other comorbidities. Further, because heart failure is the number one driver of hospitalization globally, it is critically important that we eliminate age bias in the healthcare system in order to detect and diagnose heart failure as early as possible.”

HF is one of 14 key themes of the ESC Congress 2019 / World Congress of Cardiology, which include topics ranging from preventative cardiology to e-cardiology and digital health. Of the 84 HF sessions, two include presentations that focus on older patients. GCOA supports the effort to include HF’s impact on older adults in the broader conversation on global cardiovascular health but recognizes more attention is needed on the role ageism plays in patient detection, diagnosis, treatment, and care.

As a result of ageist assumptions, adults 50 and over are routinely under-recognized, under-diagnosed, and under-treated. The “ageism factor” assumes HF symptoms, such as fatigue and shortness of breath, are a normal part of aging rather than signs of disease. With the global population over 60 expected to reach 2 billion by mid-century, the number of people at risk for HF is on the rise.

HF affects 26+ million people with approximately 80% of patients over the age of 65. Even while mortality rates for other chronic conditions have continued to improve, the rates for HF have stagnated, and still the majority of patients die within five years of initial hospital admission. HF hospitalization, readmissions, and the related costs continue to grow. As the World Health Organization kicks off its Decade of Healthy Ageing (2020-2030) in May, this year’s ESC is a pivotal time for CVD experts to focus on the link between aging and HF to combat the projected 127% increase in direct and indirect HF costs expected by 2030.

To help illuminate the connection between HF and aging, GCOA is pleased to be partnering with like-minded organizations to create the Global Heart Failure Alliance. The Alliance is already increasing awareness of this connection, aimed at enabling patients, caregivers, and health care providers to take early action, quantify the costs associated with HF, and identify levers to alleviate those costs. The Alliance is focused on:

  • Growing and convening cross-sector, cross-discipline, and cross-geography experts who recognize and wish to elevate the connection between HF and aging;
  • Developing and distributing a Heart Failure Consensus Statement with calls to action;
  • Reexamining the Heart Failure Patient Hospitalization Journey to evaluate the full scope of those at risk and associated costs; and
  • Identifying Global Best Practices in Heart Failure.

“GCOA looks forward to continuing the efforts of the Global Heart Failure Alliance alongside leading cardiovascular experts and organizations, including ESC and WHF, to shine a light on the full scope of heart failure’s impact through the lens of aging and therefore the potential to improve patients’ quality of life and reduce health system costs,” said Hodin.

The launch session of WHF’s Roadmap for Heart Failure (Expert Advice – Optimising the organisation of heart failure care) will take place on Monday 2 September, 16:40-17:50 at the Paris Convention Centre.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.